HoneyNaps

HoneyNaps operates in the digital healthcare sector, focusing on developing technologies for disease diagnosis, bio signal monitoring, and treatment assessments. The company serves medical professionals and researchers by providing a platform that facilitates disease prediction and bio signal management. HoneyNaps' core product, SOMNUM, is a breakthrough platform technology designed to collect and analyze bio signals, such as body temperature, heart rate, and movement during sleep, to detect abnormal symptoms early. The business model revolves around offering a shared platform that integrates these technologies into clinical practice, aiming to make healthcare more accessible and personalized. HoneyNaps generates revenue by licensing its platform and technologies to healthcare providers and researchers, contributing to the advancement of 4P Medicine—Prevention, Prediction, Participation, and Personalization. The company is committed to improving global health outcomes by leveraging its expertise in bio signal analysis and disease prediction algorithms.

Keywords: bio signal, disease prediction, sleep monitoring, healthcare platform, SOMNUM, clinical practice, data analysis, medical professionals, 4P Medicine, digital healthcare.